CAR T cells with upgraded cell signaling shrink ovarian cancer tumors in mice better than standard CAR T cells, according to recent study results.
CAR T cells with upgraded cell signaling shrink ovarian cancer tumors in mice better than standard CAR T cells, according to recent study results.